ALDH1A1 and breast carcinoma: However, ALDH1+ BCSCs are associated with HER-2 overexpression and loss of expression of oestrogen receptors and progesterone receptors (Ginestier et al., 2007), and the presence of this population may be used as an independent predictor of breast cancer prognosis (Mansour & Atwa, 2015).